Johnson and Johnson asked to cut down price of new TB drug Industry-Economic Times — October 23, 2018 comments off ?? To ensure the drug is accessible to all, MSF called on J&J to issue a non-exclusive license to the Medicines Patent Pool to allow for price-lowering competition among generic producers.